ARTICLE | Clinical News
Celltrion preclinical data
March 15, 2010 7:00 AM UTC
In mice, CT120 protected against H5N1 and pandemic and seasonal H1N1 influenza viruses. The broad-spectrum mAb also exhibited a therapeutic effect in mice infected with H5N1. ...